Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Cancer Metastatic × evolocumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Lung Cancer Metastatic 1 Hyperlipoproteinemia Type II 1 Glioma 1 Glioblastoma 1 Coronary Disease 1 Carcinoma, Non-Small-Cell Lung 1 Atherosclerosis 1

Interventions

tremelimumab 1 regramostim 1 osimertinib 1 evolocumab 1 durvalumab 1 Radiotherapy 1 Radiation 1 Nivolumab 1 MLN 8237 1 Ipilimumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05144529 2025-04-17

TOP2101

Duke University

Phase 2 Active not recruiting

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡